RECRUITING

Examining Interactions Between PALS and Caregivers

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and their caregivers. The question is, What are the effects of communicative interaction on verbal communication in people with ALS when they interact with their caregivers and does this change over time? Participants will read words and sentences while they are interacting with their caregivers.

Official Title

Examining Interactions Between Persons with ALS and Caregivers

Quick Facts

Study Start:2025-01-22
Study Completion:2029-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06819124

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * diagnosis of ALS following the revised EL Escorial criteria
  2. * no history of other neurological conditions (e.g., stroke)
  3. * no cognitive impairment assessed by Telephone Montreal Cognitive Assessment (mini MoCA)
  4. * detectable speech disturbance according to the ALS Functional Rating Scale-Revised (ALSFRS-R)
  5. * the ability to produce single words
  6. * being a native speaker of American English (AE).
  7. * being a caregiver of a participant with ALS
  8. * being a native speaker of American English (AE).
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Anne Olmstead, Ph.D.
CONTACT
814-867-3373
ajo150@psu.edu
Navin Viswanathan, Ph.D
CONTACT
814-867-2340
nxv175@psu.edu

Principal Investigator

Jimin Lee, Ph.D.
PRINCIPAL_INVESTIGATOR
Penn State University
Anne Olmstead, Ph.D.
PRINCIPAL_INVESTIGATOR
Penn State University
Navin Viswanathan, Ph.D.
PRINCIPAL_INVESTIGATOR
Penn State University

Study Locations (Sites)

Speech Core, Pennsylvania State University
University Park, Pennsylvania, 16802
United States

Collaborators and Investigators

Sponsor: Penn State University

  • Jimin Lee, Ph.D., PRINCIPAL_INVESTIGATOR, Penn State University
  • Anne Olmstead, Ph.D., PRINCIPAL_INVESTIGATOR, Penn State University
  • Navin Viswanathan, Ph.D., PRINCIPAL_INVESTIGATOR, Penn State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-22
Study Completion Date2029-02-28

Study Record Updates

Study Start Date2025-01-22
Study Completion Date2029-02-28

Terms related to this study

Additional Relevant MeSH Terms

  • Amyotrophic Lateral Sclerosis (ALS)